View in EDS

POSA370 Healthcare Resource Use By European Patients Enrolled in RA-be-Real: A Multinational, Prospective, Observational Study of the Effectiveness, Healthcare Resource Utilization and Costs in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic or Biologic Disease Modifying Therapies

Saved in:
Bibliographic Details
Title: POSA370 Healthcare Resource Use By European Patients Enrolled in RA-be-Real: A Multinational, Prospective, Observational Study of the Effectiveness, Healthcare Resource Utilization and Costs in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic or Biologic Disease Modifying Therapies
Authors: Alten, R1 (AUTHOR), Burmester, G2 (AUTHOR), Matucci-Cerinic, M3 (AUTHOR), Salmon, JH4 (AUTHOR), Zaremba-Pechmann, L5 (AUTHOR), Fakhouri, W5 (AUTHOR), de La Torre, I5 (AUTHOR), Herrera, M5 (AUTHOR), Holzkämper, T5 (AUTHOR), Fautrel, B6 (AUTHOR)
Source: Value in Health. 2022 Supplement, Vol. 25 Issue 1, pS221-S221. 1p.
Database: Academic Search Ultimate
Description
ISSN:10983015
DOI:10.1016/j.jval.2021.11.1081